Yaping Sun | Molecular Biology | Research Excellence Award

Published on by Molecular Biologist

Dr. Yaping Sun | Molecular Biology | Research Excellence Award

Associate Senior Research Fellow | Institute of Tsinghua university in shenzhen | China

Dr. Yaping Sun is an accomplished molecular biologist and Associate Senior Research Fellow at the Institute of Tsinghua University, Shenzhen. She is internationally recognized for her contributions to protein structural biology, epigenetic regulation, and DNA polymerase engineering. Her interdisciplinary research bridges fundamental molecular mechanisms with translational biotechnology, advancing both basic biology and applied diagnostics. Dr. Sun has revealed mechanisms of parental histone inheritance, developed engineered DNA polymerases with enhanced activity, and established microfluidics-based enzyme evolution platforms. She leads competitively funded programs, with 5 published documents, 10 citations by 7 documents, and an h-index of 2.

Citation Metrics (Scopus)

100

80

60

40

20

0

Citations
10

Documents
5

h-index
2

        🟦 Citations    🟥 Documents    🟩 h-index


View Scopus Author Profile
 View Google Scholar Author Profile

Featured Publications

Maryam Sharzehee | Molecular Biology | Excellence in Research Award

Published on by Molecular Biologist

Assist. Prof. Dr. Maryam Sharzehee | Molecular Biology | Excellence in Research Award 

Lecturer | Yazd University | Iran

Assist. Prof. Dr. Maryam Sharzehee is a distinguished textile engineering scholar specializing in textile chemistry, advanced finishing technologies, and functional polymer systems. She focuses on innovative and sustainable textile materials, including antibacterial and flame-retardant treatments, nano-enabled and smart textiles, functional hydrogels, and polymer-based medical and bio-textiles. Her research emphasizes environmentally friendly chemical finishing agents and practical applications in textile science. Dr. Sharzehee’s work is internationally recognized through publications in high-impact journals, invited conference presentations, and applied research contributions. To date, she has authored 15 documents, cited 67 times, with an h-index of 5, demonstrating her significant impact in textile engineering.

 

Citation Metrics (Scopus)

80
60
40
20
0

Citations
67

Documents
15

h-index
5

        🟦 Citations    🟥 Documents    🟩 h-index


View Scopus Author Profile
 View Google Scholar Author Profile

Featured Publications

Essa M. Saied | Molecular Biology | Research Excellence Award

Published on by Molecular Biologist

Assoc. Prof. Dr. Essa M. Saied | Molecular Biology | Research Excellence Award 

Associate Professor | Humboldt University of Berlin | Germany

Associate Prof. Dr. Essa M. Saied is a distinguished biochemist and bioorganic chemist whose work advances synthetic medicinal chemistry, lipid biochemistry, and small-molecule drug discovery. Holding research appointments at Humboldt University of Berlin and Suez Canal University, he has built an international reputation through 72 published documents, 2,232 citations from 1,538 citing sources, and an h-index of 31. His research integrates organic synthesis, lipid biochemistry, and computational design to identify small-molecule inhibitors of key sphingolipid-metabolizing enzymes. He employs high-throughput screening, enzymatic assays, molecular modeling, and structure–activity analysis to explore biochemical pathways relevant to cancer, inflammation, and metabolic disorders. His work also develops heterocyclic scaffolds, fluorescent probes, and biochemical tools that deepen understanding of lipid signaling and enzyme function. Through editorial service, peer review, and global collaboration, he continues to contribute significantly to chemical biology and therapeutic innovation.

Profiles: Scopus | ORCID| Google Scholar

Featured Publications

Live-Cell Identification of CERT Inhibitors via NanoBRET. Angewandte Chemie, Impact Factor 16.1.

Small-Molecule Ceramidase Inhibitors: Mechanism of Action. Angewandte Chemie, Impact Factor 16.8.

Stereoselective Synthesis of Novel Sphingoid Bases. International Journal of Molecular Sciences, Impact Factor 6.21.

Subunit Composition of Serine-Palmitoyltransferase. Proceedings of the National Academy of Sciences (PNAS), Impact Factor 11.2.

Resolving Sphingolipid Isomers Using Cryogenic IR Spectroscopy. Angewandte Chemie, Impact Factor 15.3.

RAJKUMAR MANICKAM | Molecular Biology | Molecular Biology Scientist Award

Published on by Molecular Biologist

Assist. Prof. Dr. RAJKUMAR MANICKAM | Molecular Biology | Molecular Biology Scientist Award 

Assistant Professor | Karpagam Academy of Higher Education | India

Assist. Prof. Dr. Manickam Rajkumar is an accomplished scientist recognized for his work in nanotechnology, molecular biology, and biomedical applications. His research spans biopolymer-based nanocomposites, green nanotechnology, drug delivery systems, and therapeutic strategies for neurodegenerative diseases, cancer, and microbial infections. With strong interdisciplinary training and extensive experience in in vitro, in vivo, and in silico methodologies, he contributes to advanced material synthesis, biomolecular characterization, behavioural neuroscience, and molecular diagnostics. His studies have identified nanocomposites with significant antioxidant capacity, modulation of toxic protein aggregation, and cognitive enhancement potential in disease models. His research interests include computational biology, biomedical coatings, metal oxide nanostructures, metabolic disorder therapeutics, and marine bioactive materials. He has produced impactful scientific contributions reflected in 325 citations, 232 citing documents, 27 publications, and an h-index of 11. His work has earned competitive fellowships and multiple best presentation awards at major scientific conferences, underscoring his influence as a growing researcher in biomedical innovation.

Profiles: Scopus | ORCID | Google Scholar
Featured Publications

Biosynthesis of cerium oxide nanoparticles. Biomedical Materials & Devices.

Review on green synthesis of nanoparticles. Biomedical Materials & Devices.

Biosynthesis of chitosan–TiO₂ nanoparticles. Inorganic Chemistry Communications.

CuO nanoparticles for colon cancer therapy. Journal of Cluster Science.

NanoMarine therapeutics for colon cancer. Frontiers in Genetics.

Eco-friendly synthesis of ZnO nanoparticles. Inorganic Chemistry Communications.

Sooyoung Kim | Molecular Biology | Editorial Board Member

Published on by Molecular Biologist

Dr. Sooyoung Kim | Molecular Biology | Editorial Board Member

Industry | US Neurophth Therapeutics (Ex-) | United States

Soo-Young Kim is an accomplished researcher specializing in retinal biology, neurodegeneration, and therapeutic development for ocular diseases. He holds a PhD in Medicine from Korea University and has extensive experience across academia and industry, including positions at UC Irvine, Neurophth Therapeutics, ExosomePlus, Johns Hopkins Wilmer Eye Institute, and the National Eye Institute. His research focuses on retinal development, age-related macular degeneration, and neovascularization, with significant contributions to understanding photoreceptor synapse formation, retinal degeneration models, and inflammatory pathways in pathological neovascularization. Kim has authored numerous publications in high-impact journals, advancing both basic science and translational applications in ophthalmology. His work combines molecular, cellular, and whole-mount techniques to elucidate disease mechanisms and support drug evaluation, reflecting a strong commitment to bridging experimental research with therapeutic innovation.

Profile: ORCID

Featured Publications

Kim, S.-Y., Park, C. H., Moon, B.-H., & Seabold, G. K. Murine Retina Outer Plexiform Layer Development and Transcriptome Analysis of Pre-Synapses in Photoreceptors. Life, 14(9), 1103.

Moon, B.-H., Kim, Y., & Kim, S.-Y. Twenty Years of Anti-Vascular Endothelial Growth Factor Therapeutics in Neovascular Age-Related Macular Degeneration Treatment. International Journal of Molecular Sciences, 24(16), 13004.

Kim, S.-Y., & Qian, H. Comparison between sodium iodate and lipid peroxide murine models of age-related macular degeneration for drug evaluation—a narrative review. Annals of Eye Science, 7, Article 25.

Kim, S.-Y., Zhao, Y., Kim, H.-L., Oh, Y., & Xu, Q. Sodium iodate-induced retina degeneration observed in non-separate sclerochoroid/retina pigment epithelium/retina whole mounts. Annals of Eye Science, 7, Article 27.

Lee, S.-J., & Kim, S.-Y. Mouse Sclerochoroid/RPE/Retina posterior eyeball staining and Whole Mounts. BIO-PROTOCOL, 11(15), e3872.

Kim, S.-Y. Inflammatory pathways in pathological neovascularization in retina and choroid: a narrative review on the inflammatory drug target molecules in retinal and choroidal neovascularization. Annals of Eye Science, 6, Article 4.

Georges Nemer | Molecular Biology | Editorial Board Member

Published on by Molecular Biologist

Prof. Georges Nemer | Molecular Biology | Editorial Board Member 

Professor | Hamad Bin Khalifa University | Qatar

Dr. Georges Nemer is a prominent molecular cardiology and biomedical research expert whose work spans cardiac development, congenital heart defects, transcriptional regulation, and translational molecular biology. His research has uncovered key mechanisms governing cardiogenesis, including defining the role of the T-box transcription factor Tbx5 in heart formation and disease, demonstrating how GATA-4 overexpression enhances cardiogenesis in embryonic stem cells, and revealing the cooperative regulation of myocardial gene expression by GATA-4 and GATA-6. Dr. Nemer has also contributed to clinical genetics through the identification of novel GATA4 mutations associated with Tetralogy of Fallot, supporting improved understanding of congenital heart malformations. Beyond cardiology, his scholarship extends to dermatological science, elucidating molecular pathways and clinical applications of retinoids, and to computational biochemistry through work on protein-ligand docking using AutoDock for targets such as BACE1. His interdisciplinary portfolio reflects a commitment to bridging basic science and clinical relevance, advancing knowledge across cardiac biology, human genetics, molecular therapeutics, and biomedical modeling.

Profile: Google Scholar

Featured Publications

Bruneau, B. G., Nemer, G., Schmitt, J. P., Charron, F., Robitaille, L., Caron, S., …
(2001). A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease. Cell, 106(6), 709–721.

Grépin, C., Nemer, G., & Nemer, M. (1997). Enhanced cardiogenesis in embryonic stem cells overexpressing the GATA-4 transcription factor. Development, 124(12), 2387–2395.

Charron, F., Paradis, P., Bronchain, O., Nemer, G., & Nemer, M. (1999). Cooperative interaction between GATA-4 and GATA-6 regulates myocardial gene expression. Molecular and Cellular Biology, 19(6), 4355–4365.

Khalil, S., Bardawil, T., Stephan, C., Darwiche, N., Abbas, O., Kibbi, A. G., …
(2017). Retinoids: A journey from the molecular structures and mechanisms of action to clinical uses in dermatology and adverse effects. Journal of Dermatological Treatment, 28(8), 684–696.

Nemer, G., Fadlalah, F., Usta, J., Nemer, M., Dbaibo, G., Obeid, M., & Bitar, F. (2006). A novel mutation in the GATA4 gene in patients with Tetralogy of Fallot. Human Mutation, 27(3), 293–294.

El-Hachem, N., Haibe-Kains, B., Khalil, A., Kobeissy, F. H., & Nemer, G. (Year unavailable). AutoDock and AutoDockTools for protein-ligand docking: Beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) as a case study. Neuroproteomics: Methods and Protocols, 391–403.

ZHANG TING | Molecular Biology | Young Scientist Award

Published on by Molecular Biologist

Ms. ZHANG TING | Molecular Biology | Young Scientist Award 

Teacher | China Kashi University | China

Dr. Zhang Ting is a distinguished Chinese biologist specializing in biological resources, nutritional biochemistry, and translational medicine. He earned his Bachelor of Nutrition, Master’s in Nutritional Studies, and Doctor of Biology from Hoseo University, South Korea, focusing on integrative nutrition, functional foods, and systems biology. His doctoral research explored neuropharmacological mechanisms in Alzheimer’s disease, stroke, diabetes, and obesity, combining molecular assays, rodent behavioral studies, and herbal medicine bioactivity. With over a decade of laboratory experience, Zhang has worked at Hoseo University and YEJUN Institute of Biological Sciences, leading experiments on metabolic regulation, neuroprotection, and chronic disease models while mentoring junior scientists and overseeing laboratory safety. His research interests include gut-brain axis modulation, herbal and fermented food interventions, metabolic disorders, and diet-based cognitive enhancement. Zhang bridges traditional medicinal knowledge with modern translational medicine, aiming to develop innovative strategies for chronic disease mitigation. His work has been widely cited and recognized internationally, reflecting his contributions to nutritional biochemistry, neuropharmacology, and functional food research, positioning him as a rising leader in integrative biomedical science.

Profile: ORCID

Featured Publications

Zhang, T., & Park, S. (n.d.). Network pharmacology-guided discovery of traditional Chinese medicine extracts for Alzheimer’s disease: Targeting neuroinflammation and gut-brain axis dysfunction. Int J Mol Sci, 26(17), 8545. Cited by 12.

Zhang, T., & Park, S. (n.d.). Energy intake-dependent genetic associations with obesity risk: BDNF Val66Met polymorphism and interactions with dietary bioactive compounds. Antioxidants, 14(2), 170.

Zhang, T., Yue, Y., Li, C., et al. (n.d.). Vagus nerve suppression in ischemic stroke by carotid artery occlusion: Implications for metabolic regulation, cognitive function, and gut microbiome in a gerbil model. Int J Mol Sci, 25, 7831.

Zhang, T., Li, C., Yue, Y., et al. (n.d.). Fermented red pepper paste (Kochujang) modulates glucose metabolism and gut microbiota in parasympathetic suppression: Network pharmacology and in vivo study. Food Biosci, 104531.

Zhang, T., Yue, Y., Jeong, S. J., et al. (n.d.). Improvement of estrogen deficiency symptoms by long-term fermented soybeans (Doenjang) rich in Bacillus species through modulating gut microbiota in estrogen-deficient rats. Foods, 12(6), 1143.

Laura Estrada | Molecular Biology | Best Researcher Award

Published on by Molecular Biologist

Prof. Laura Estrada | Molecular Biology | Best Researcher Award 

Researcher | Physics department University of Buenos Aires | Argentina

Prof. Laura Cecilia Estrada is a physicist, educator, and researcher whose work bridges advanced optical microscopy, nanotechnology, and interdisciplinary biophysics. She serves as Adjunct Professor at the Department of Physics, University of Buenos Aires and Independent Researcher at CONICET, where she leads pioneering investigations in fluorescence spectroscopy, nanoimaging, and virus-host interactions. Estrada completed her academic training in physics at the University of Buenos Aires, earning her Licenciatura and Ph.D. with highest distinction, and later expanded her expertise as a postdoctoral researcher and group leader at the University of California, Irvine. Her research focuses on fluorescence-based techniques, single-particle tracking, and nano-optics applied to both fundamental physics and biomedical sciences, with special emphasis on dengue and Zika virus proteins. Alongside her scientific contributions, she has played key leadership roles in professional societies and gender equity initiatives. Her work has been recognized nationally and internationally, including awards from the International Commission for Optics, the Biophysical Society, and Argentina’s INNOVAR program. She has supervised numerous theses, mentored young scientists, and fostered international collaborations. With 35 publications, 325 citations, and an h-index of 9, Estrada exemplifies scientific rigor, innovation, and social commitment in advancing both knowledge and equity.

Profile: Scopus

Featured Publications

Sallaberry, I., & Estrada, L. Unraveling viral protein-host membrane interaction for dengue and Zika. Biophysical Journal.

Leon, A., Sallaberry, I., Estrada, L., & Scorticati, C. Non-synonymous SNPs within GPM6A impair hippocampal neuron development. Biochimica et Biophysica Acta, 1872(3). Cited by 2.

Salzman, V., & Estrada, L. Replicative lifespan determination of yeast using microfluidic chip. Biology Open, 13(11). Cited by 5.

Gaggioli, E., Estrada, L., & Bruno, O. Boundary layer structures in transport theory. Physical Review E, 110. Cited by 3.

Philipp, N., Gratton, E., & Estrada, L. Protein-membrane interaction via radial FCS. Methods and Applications in Fluorescence, 11(4). Cited by 12.

Gabriel, M., & Estrada, L. Dengue Virus Capsid Protein Dynamics in live cells. Scientific Reports, 10. Cited by 45.

Maria Camprubi Robles | Molecular Biology | Best Researcher Award

Published on by Molecular Biologist

Dr. Maria Camprubi Robles | Molecular Biology | Best Researcher Award 

Research Scientist | Abbott Laboratories | Spain

Dr. Maria Camprubi is a highly accomplished Research Scientist with over a decade of dedicated service at Abbott Nutrition, specializing in molecular and cellular biology. With strong expertise in nutritional science, she has significantly contributed to the development of innovative products that address sarcopenia, chronic disease, and malnutrition across Europe, the Middle East, and Africa. She holds a Ph.D. in Molecular and Cellular Biology, where she built a strong foundation in cellular processes and metabolic regulation. Her academic training provided the expertise to bridge laboratory research with clinical nutrition, forming the cornerstone of her impactful scientific career.  Dr. Camprubi has worked at Abbott in the R&D department, leading projects that focus on the nutritional management of vulnerable populations. Her experience spans cross-functional collaborations, clinical trials, and translating research into practical solutions that improve health outcomes globally. Her research interests focus on nutrition metabolism to support muscle health, healthy aging, oncology, and diabetes. She aims to create evidence-based interventions that help prevent muscle decline, enhance recovery during chronic illnesses, and promote long-term well-being in aging populations. Dr. Camprubi has been recognized within Abbott for her leadership in advancing nutritional innovation. Her commitment to applying molecular and clinical insights to product development has positioned her as a leading scientist driving transformative changes in health and nutrition. She has authored impactful publications in peer-reviewed journals, contributing knowledge on nutritional metabolism, sarcopenia, and disease-related malnutrition. Her scientific contributions have achieved 1,276 citations by 1,194 documents, with 24 published documents and an h-index of 17, reflecting her influence in the scientific community and the value of her contributions to global health research.

Profile: Scopus

Featured Publications

A prospective, observational study of the effect of a high-calorie, high-protein oral nutritional supplement with HMB in an old and malnourished or at-risk-of-malnutrition population with hip fractures: A FracNut study. Nutrients, 16(8)

The vicious cycle of type 2 diabetes mellitus and skeletal muscle atrophy: Clinical, biochemical, and nutritional bases. Nutrients, 16(1), 172

Shangze Li | Molecular Biology | Best Researcher Award

Published on by Molecular Biologist

Assoc. Prof. Dr. Shangze Li | Molecular Biology | Best Researcher Award 

Assistant to the Dean | Chongqing University | China

Dr. Shangze Li (Ph.D., Associate Professor, Ph.D. Supervisor) is a distinguished researcher in the fields of antiviral innate immune signaling, inflammatory responses, and tumor biology. He is based at the School of Medicine, Chongqing University, where he leads a research group and supervises doctoral students. His work integrates advanced genetic engineering technologies such as gene knockout, knock-in approaches, and disease models to investigate the molecular basis of immune regulation and cancer development. Dr. Li has published extensively in leading international journals including Nature Communications, Cell Death and Differentiation, Cancer Research, Oncogene, and Cancer Letters, with several contributions featured in Nature Index journals. His studies have been widely cited, reflecting both scientific impact and relevance to the global biomedical community. In addition to research, he is actively involved in teaching, mentoring, editorial service, and academic leadership, contributing to the advancement of both education and medical research.

Professional Profile

Scopus

ORCID

Google Scholar

Education 

Dr. Li completed his doctoral degree in Cell Biology at Wuhan University, where he focused on the molecular mechanisms that link immune regulation to tumorigenesis. Prior to his doctoral training, he pursued two undergraduate degrees, one in Bioengineering from the Chengdu University of Technology and another in Business Administration from the University of Electronic Science and Technology of China. This unique combination of scientific and managerial education provided him with both technical expertise and leadership skills. After completing his doctorate, Dr. Li undertook postdoctoral training at the Feinberg School of Medicine, Northwestern University, where he worked on projects exploring molecular oncology, innate immunity, and translational approaches in cancer research. His diverse academic background, spanning engineering, business, molecular biology, and medical research, has prepared him to integrate interdisciplinary knowledge in his career. This foundation continues to guide his role as a scientist, supervisor, and contributor to medical and biological sciences.

Experience 

Dr. Li began his professional research career at the Feinberg School of Medicine, Northwestern University, where he served as a postdoctoral researcher in molecular oncology and immune regulation. Following this period of international training, he returned to China and accepted an appointment at Zhongnan Hospital of Wuhan University and the College of Life Sciences, where he contributed to teaching and research in biomedical sciences. He later joined the School of Medicine at Chongqing University as a faculty member, where he was subsequently promoted to Associate Professor and Ph.D. Supervisor. In this role, he leads a laboratory focused on investigating immune signaling and cancer development. In addition to his research and teaching, Dr. Li has taken on administrative responsibilities, serving as Assistant to the Dean and Deputy Director of Shared Core Facilities for Medical Research. His experience reflects a career that balances leadership, education, and internationally recognized scientific research.

Research Interests 

Dr. Li’s research centers on the molecular mechanisms of innate immune signaling, inflammation, and tumor biology. His work explores how signaling pathways regulate immune homeostasis and contribute to tumor initiation and progression. He employs genetically modified cell lines, CRISPR-based technologies, and animal models to examine the functional roles of key genes in these processes. His studies often focus on ubiquitination and deubiquitination pathways, NF-κB signaling, and the crosstalk between cellular metabolism and cell death. This approach provides critical insights into how molecular dysregulation drives oncogenesis and resistance to therapy. His research also emphasizes translational applications, identifying potential biomarkers and therapeutic strategies that may guide novel approaches in cancer treatment and immune-related diseases. By integrating molecular biology, immunology, and cancer research, Dr. Li contributes to advancing both fundamental scientific knowledge and practical innovations for improving health outcomes.

Awards 

Dr. Li’s research achievements have been recognized through broad citation and publication in top international journals. His scholarly contributions have been acknowledged in Nature Communications, Molecular Cancer, Cancer Research, and other leading journals, with some articles featured as cover stories in Nature Index publications. His body of work has earned substantial recognition in the scientific community, reflected in a strong citation record and consistent invitations to review for leading journals. He has also served as Guest Editor for Vaccines and as a reviewer for the National Natural Science Foundation of China, underscoring his role as a trusted scientific evaluator. Beyond research output, Dr. Li has contributed actively to professional organizations, including serving as a council member of the Chongqing Association of Young Scientists and participating in national academic initiatives. His record demonstrates recognition for both scholarly impact and professional service, positioning him as a strong candidate for scientific honors.

Top Noted Publications 

Dr. Li has authored more than forty peer-reviewed publications, including a substantial number as first or corresponding author. His research has appeared in high-impact journals such as Nature Communications, Molecular Cancer, Oncogene, Cancer Research, and Cancer Letters. Selected publications include Ubiquitin-Specific Protease 1 Promotes Bladder Cancer Progression in Cells, CLK2 mediates NF-κB regulation in Nature Communications, Crosstalk between metabolism and cell death in tumorigenesis in Molecular Cancer, USP14 promotes colorectal cancer progression in Cell Death & Disease, and MAPK signaling and drug resistance in prostate cancer in Cancer Research. These publications reflect his long-term focus on the molecular basis of immune regulation and cancer biology. His findings have been widely cited and have advanced understanding of tumorigenesis, therapeutic resistance, and immunoregulation. Collectively, his research portfolio highlights his contributions to both fundamental science and translational medicine, strengthening his standing as an influential scholar in the field of biomedical research.

Title: Ubiquitin-Specific Protease 1 Promotes Bladder Cancer Progression
Journal: Cells
Year: 2024
Cited by: 15+

Title: CLK2 mediates IkappaBalpha-independent NF-κB regulation
Journal: Nature Communications
Year: 2024
Cited by: 30+

Title: Crosstalk between metabolism and cell death in tumorigenesis
Journal:  Molecular Cancer
Year: 2024
Cited by: 40+

Title: USP14 promotes colorectal cancer progression
Journal: Cell Death & Disease
Year: 2023
Cited by: 25+

Title: Activation of MAPK by CXCR7 causes drug resistance
Journal: Cancer Research
Year: 2019
Cited by: 200+

Conclusion

Dr. Shangze Li is a highly suitable candidate for the Best Researcher Award. His outstanding research achievements, strong academic influence, and balanced contributions to teaching, mentorship, and professional service highlight his excellence as a scholar. With continued focus on international collaboration, high-impact publications, and global leadership roles, he is exceptionally well-positioned to be recognized with this award.